Author:
Landeros-Martinez Linda-Lucila,Glossman-Mitnik Daniel,Orrantia-Borunda Erasmo,Flores-Holguin Norma
Reference55 articles.
1. Weidner N, Cady B, Goodson 3rd W. Pathologic prognostic factors for patients with breast carcinoma. Which factors are important. Surgical Oncology Clinics of North America. 1997;6(3):415-462
2. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. The Lancet. 1997;349(9069):1864-1867
3. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. Journal of Clinical Oncology. 2002;20(17):3628-3636
4. Molina M, Reigosa A, Nobrega D, Molina Y. Receptores de estrógeno y progesterona en cáncer de mama. Asociacion con variables clinicopatologicas. Revista Salus Online Facultad de Ciencias de la Salud Universidad de Carabobo (Valencia-Venezuela). 2001;5:34-42
5. Lai A, Kahraman M, Govek S, Nagasawa J, Bonnefous C, Julien J, et al. Identification of GDC-0810 (ARN-810), an orally bioavailable selective estrogen receptor degrader (SERD) that demonstrates robust activity in tamoxifen-resistant breast cancer xenografts. Journal of Medicinal Chemistry. 2015;58(12):4888-4904
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献